Sukhyang Lee Selected Research

Coronary Disease (Coronary Heart Disease)

1/2019	ARB Superiority Over ACE Inhibitors in Coronary Heart Disease: An Alternative Viewpoint.
11/2018	Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sukhyang Lee Research Topics

Disease

4	Hemorrhage 01/2020 - 11/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 01/2016
3	Dementia (Dementias) 01/2023 - 01/2018
3	Hypertension (High Blood Pressure) 01/2023 - 11/2016
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2020 - 01/2016
3	Premature Ejaculation 07/2014 - 04/2013
2	Neoplasms (Cancer) 01/2023 - 01/2020
2	Liver Diseases (Liver Disease) 01/2023 - 07/2009
2	Type 2 Diabetes Mellitus (MODY) 04/2019 - 01/2018
2	Coronary Disease (Coronary Heart Disease) 01/2019 - 11/2018
2	Diabetes Mellitus 11/2016 - 01/2016
1	Hemophilia A (Haemophilia) 04/2024
1	Wounds and Injuries (Trauma) 03/2024
1	Acute Kidney Injury (Acute Renal Failure) 06/2023
1	Atrial Fibrillation 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Diabetes Complications 04/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Stroke (Strokes) 01/2019
1	Cerebral Hemorrhage 01/2019
1	Myocardial Infarction 02/2018
1	Ischemic Stroke 02/2018
1	Disease Progression 02/2018
1	Cardiac Arrhythmias (Arrythmia) 09/2015
1	Flushing 01/2014
1	Hyperphosphatemia 01/2014

Drug/Important Bio-Agent (IBA)

6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 01/2016
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 11/2016
3	Angiotensin Receptor AntagonistsIBA 11/2018 - 11/2016
3	DA 8031IBA 07/2014 - 04/2013
2	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 07/2009
2	sarpogrelateIBA 04/2019 - 01/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 04/2019 - 01/2018
2	Cilostazol (Pletal)FDA LinkGeneric 02/2018 - 01/2018
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 07/2014 - 03/2014
2	Warfarin (Coumadin)FDA LinkGeneric 03/2007 - 11/2003
1	Factor VIII (Coagulation Factor VIII)IBA 04/2024
1	Ezetimibe (Zetia)FDA Link 03/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2023
1	DiureticsIBA 01/2023
1	Rosuvastatin Calcium (Crestor)FDA Link 02/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 04/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2019
1	ReninIBA 04/2019
1	AngiotensinsIBA 04/2019
1	AldosteroneIBA 04/2019
1	LipidsIBA 11/2018
1	Glucose (Dextrose)FDA LinkGeneric 11/2016
1	ThiazidesIBA 11/2016
1	Monoclonal AntibodiesIBA 09/2015
1	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 07/2014
1	benzylamineIBA 07/2014
1	Serotonin (5 Hydroxytryptamine)IBA 07/2014
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2014
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2014
1	SuspensionsIBA 01/2014
1	MK-0524IBA 01/2014
1	p-ChloroamphetamineIBA 04/2013
1	HM70186IBA 07/2009
1	Losartan (Cozaar)FDA LinkGeneric 07/2009
1	Cytochrome P-450 CYP2C19IBA 03/2007
1	Cytochrome P-450 CYP2C9IBA 11/2003

Therapy/Procedure

8	Therapeutics 01/2023 - 11/2003
1	Secondary Prevention 01/2019
1	Transplantation 02/2018
1	Renal Dialysis (Hemodialysis) 02/2018